Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Swift, Certain, and Fair: Reducing Recidivism and Improving Outcomes for Alcohol and Drug Users on State Parole

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03826420
Recruitment Status : Not yet recruiting
First Posted : February 1, 2019
Last Update Posted : March 11, 2019
Sponsor:
Collaborators:
Pennsylvania Department of Corrections
Bureau of Justice Assistance
Information provided by (Responsible Party):
Botec Analysis, LLC

Brief Summary:

This research project will study the outcomes of medium- to high-risk parolees with a history of substance abuse in Alleghany County, Pennsylvania supervised under Swift-Certain-Fair parole.

The research goals are to:

  • Determine the effectiveness of SCF parole in reducing recidivism among medium- to high-risk parolees with a history of substance abuse in Pennsylvania.
  • Determine the minimum effective sanction in response to a violation that will bring parolees into compliance with the conditions of their parole.

Condition or disease Intervention/treatment Phase
Substance Abuse Criminal Behavior Behavioral: SCF Supervision with Secure Confinement Sanctioning Behavioral: SCF Supervision with Work Release Sanctioning Behavioral: SCF Supervision with GPS Supervision Sanctioning Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 250 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Masking Description: Participants (parolees) will not be notified as to which arm they are enrolled.
Primary Purpose: Prevention
Official Title: Swift, Certain, and Fair: Reducing Recidivism and Improving Outcomes for Alcohol and Drug Users on State Parole
Estimated Study Start Date : April 1, 2019
Estimated Primary Completion Date : August 15, 2020
Estimated Study Completion Date : December 31, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Drug Abuse

Arm Intervention/treatment
Experimental: Secure Confinement Group
Parolees assigned to this group will be assigned sanctions that include secure confinement.
Behavioral: SCF Supervision with Secure Confinement Sanctioning
Parolees assigned to this group will, in the face of a violation, be given a sanction that involves secure confinement.

Experimental: Work Release Group
Parolees assigned to this group will be assigned sanctions that include work-release.
Behavioral: SCF Supervision with Work Release Sanctioning
Parolees assigned to this group will, in the face of a violation, be given a sanction that involves work-release.

Experimental: GPS Supervision Group
Parolees assigned to this group will be assigned sanctions that include GPS supervision.
Behavioral: SCF Supervision with GPS Supervision Sanctioning
Parolees assigned to this group will, in the face of a violation, be given a sanction that involves GPS supervision.

No Intervention: Control Group



Primary Outcome Measures :
  1. Revocation Rate [ Time Frame: 9 Months ]
    Percentage of subjects in each condition who are revoked from parole and returned to prison


Secondary Outcome Measures :
  1. Days Incarcerated [ Time Frame: 9 Months ]
    Total number of days incarcerated in jail or prison per parolee

  2. New Charges [ Time Frame: 9 Months ]
    Number of new charges per parolee

  3. Percent Positive Drug Tests [ Time Frame: 9 Months ]
    Percentage of random and scheduled drug tests that result in a positive reading for illicit drugs



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Assigned to the Pittsburgh District
  • Allegheny County resident
  • Has at least 2 years left on supervision
  • Had a prior drug or alcohol related sanction

Exclusion Criteria:

  • Sex offender
  • Reentrants assigned to the Special Needs Unit

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03826420


Contacts
Layout table for location contacts
Contact: Clarissa Manning (424) 262-8064 clarissa.manning@botecanalysis.com

Sponsors and Collaborators
Botec Analysis, LLC
Pennsylvania Department of Corrections
Bureau of Justice Assistance
Investigators
Layout table for investigator information
Principal Investigator: Mark AR Kleiman BOTEC Analysis
Layout table for additonal information
Responsible Party: Botec Analysis, LLC
ClinicalTrials.gov Identifier: NCT03826420    
Other Study ID Numbers: BOTEC PADOC SCF
First Posted: February 1, 2019    Key Record Dates
Last Update Posted: March 11, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders